Rabat
Rabat
Rabat, Morocco12 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tranexamic Acid for Bleeding Reduction During TURP Surgery | Genital Diseases, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Urogenital Diseases, anemia, benign prostatic hyperplasia, hematologic disorder, male reproductive system disorder, prostate disorder | Recruiting | Phase 4 | 2026-10-09 | NCT07460518 | |
| A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region | Diffused Large B Cell Lymphoma; Hematology | Recruiting | Not stated | 2026-09-23 | NCT07065344 | |
| CHARM Hepatocellular Carcinoma MEA Study | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not stated | 2026-09-03 | NCT07650773 | |
| A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, severe hemophilia A | Active, not recruiting | Phase 4 | 2026-07-27 | NCT05181618 | |
| A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 3 | 2026-07-23 | NCT03523858 | |
| Dietary Supplements Among Cancer Patients: Tolerance, Impact on Medications, and Potential Drug Interactions | neoplasm | Recruiting | Not stated | 2026-06-26 | NCT07670234 | |
| Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque | Arterial Occlusive Diseases, brain disorder, cardiovascular disorder, carotid artery disorder, carotid stenosis, central nervous system disorder, cerebrovascular disorder, nervous system disorder, vascular disorder | Not yet recruiting | Phase 3 | 2026-05-14 | NCT07586540 | |
| MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis | Cerebral Venous Sinus Thrombosis | Not yet recruiting | Not applicable | 2026-04-23 | NCT07548346 | |
| A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Multiple Sclerosis, Primary Progressive, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 3 | 2026-02-23 | NCT04035005 | |
| Study Protocol: 10-Year Follow-Up of Patients Screened for Cardiovascular Risk by the "All With Heart" Association - Development of a Morocco-Specific Risk Score | cardiovascular disorder | Recruiting | Not stated | 2025-12-19 | NCT07294937 | |
| Effectiveness of Instrumental Rehabilitation in Patients With Adhesive Capsulitis | arthropathy, bursitis, frozen shoulder, musculoskeletal system disorder | Recruiting | Not applicable | 2025-02-03 | NCT06766448 | |
| Hypertension Registry: Study of Primary and Secondary Hypertension Phenotypes, Complications, and Treatment Personalization. | cardiovascular disorder, hypertensive disorder, vascular disorder | Recruiting | Not stated | 2025-01-24 | NCT06769269 |